NPCE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $12.70

Piyasa Değeri (MRQ) $435M

P/E (TTM) -22.3

Hisse Başına Kâr (TTM) $-0.57

Gelir (TTM) $99M

ROE (TTM) -122.1%

D/E Borç/Özsermaye (MRQ) 5.0

52 Haftlık Aralık $9–$20

NPCE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Neuropace, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealth Care endüstriHealth Care çalışanlar220 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$100M

2020-12-31 → 2025-12-31

Hisse Başına Kâr$-0.66

2020-12-31 → 2025-12-31

Serbest Nakit Akışı$-11M

2021-12-31 → 2025-12-31

Net kar marjı-19.3%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-22.35Y ort. ≈-9.8	≈-9.8	·	·
F/S (TTM)	4.45Y ort. ≈4.0	≈4.0	4.2	Aşırı değerli
F/D (MRQ)	36.65Y ort. ≈17.5	≈17.5	3.5	Aşırı değerli
EV / EBITDA	-26.25Y ort. ≈-13.1	≈-13.1	·	·
Fiyat / Serbest Nakit Akışı (TTM)	-37.55Y ort. ≈-17.9	≈-17.9	·	·
Fiyat / Nakit Akışı (TTM)	-38.75Y ort. ≈-18.3	≈-18.3	·	·
EV / Gelir (TTM)	4.55Y ort. ≈3.6	≈3.6	·	·
EV / FCF (TTM)	-38.15Y ort. ≈-17.2	≈-17.2	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	22.65Y ort. ≈17.5	≈17.5	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
Brüt Kar Marjı (TTM)	79.6%5Y ort. ≈74.0%	≈74.0%	76.2%	En üst düzey
Faaliyet Kâr Marjı (TTM)	-15.3%5Y ort. ≈-45.4%	≈-45.4%	-14.5%	Zayıf
EBITDA Margin (FAVÖK Marjı)	-16.3%5Y ort. ≈-45.4%	≈-45.4%	-14.5%	Zayıf
Net Kâr Marjı (TTM)	-19.3%5Y ort. ≈-57.8%	≈-57.8%	-15.2%	Zayıf
ROA (TTM)	-18.8%5Y ort. ≈-30.8%	≈-30.8%	-17.4%	Ortalamanın altında
ROE (TTM)	-122.1%5Y ort. ≈-152.2%	≈-152.2%	-39.3%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
Borç / Öz Sermaye (MRQ)	5.05Y ort. ≈3.1	≈3.1	0.7	Yüksek borç
Cari Oran (MRQ)	4.95Y ort. ≈7.9	≈7.9	4.8	Aynı seviyede
Cari Oran (MRQ)	3.85Y ort. ≈6.9	≈6.9	3.7	Aynı seviyede
Uzun Vadeli Borç / Özkaynak (MRQ)	5.05Y ort. ≈3.1	≈3.1	0.6	Yüksek borç

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	25.1%5Y ort. ≈20.3%	≈20.3%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	30.0%5Y ort. ≈22.5%	≈22.5%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	19.4%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-0.665Y ort. ≈$-1.39	≈$-1.39	·	·
Revenue / Share (Hisse Başına Gelir)	$3.065Y ort. ≈$2.58	≈$2.58	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-0.345Y ort. ≈$-0.94	≈$-0.94	·	·
Cash / Share (Hisse Başına Nakit)	$0.655Y ort. ≈$0.56	≈$0.56	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	NPCE	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	1.05Y ort. ≈0.6	≈0.6	0.7	En üst düzey
Inventory Turnover (Stok Devir Hızı)	1.55Y ort. ≈1.6	≈1.6	2.3	Zayıf
Receivables Turnover (Alacak Devir Hızı)	7.35Y ort. ≈6.5	≈6.5	7.0	Aynı seviyede
Revenue / Employee (Çalışan Başına Gelir)	≈$454.5K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 20.1%

Sonraki Rapor Kas 02, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 10, 2026	$-0.18	$-0.21	14.6%
31 Mart 2026	May 11, 2026	$-0.20	$-0.23	12.4%
31 Aralık 2025		$-0.08	$-0.15	48.2%
30 Eylül 2025		$-0.11	$-0.20	45.1%
30 Haziran 2025		$-0.26	$-0.23	-14.5%
31 Mart 2025		$-0.21	$-0.25	14.7%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 17

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$100M	$80M	$65M	$46M	$45M	$41M
Cost of Revenue	$23M	$21M	$17M	$13M	$12M	$11M
Gross Profit	$77M	$59M	$48M	$32M	$33M	$30M
R&D Expense	$28M	$24M	$21M	$22M	$18M	$16M
SG&A Expense	$19M	$17M	$55M	$51M	$39M	$28M
Operating Expenses	$94M	$81M	$75M	$73M	$57M	$43M
Operating Income	$-16M	$-22M	$-27M	$-41M	$-24M	$-13M
Interest Expense	·	·	$9M	$8M	$7M	$11M
Interest Income	$3M	$3M	$3M	$2M	$448.0K	$41.0K
Other Non-op	$-486.0K	$304.0K	$-315.0K	$-337.0K	$-5M	$218.0K
Income Tax	$0	·	·	·	·	·
Net Income	$-21M	$-27M	$-33M	$-47M	$-36M	$-24M
EPS (Basic)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	$-117.85
EPS (Diluted)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	$-117.85
Shares (Basic)	32,722,438	29,126,314	25,851,813	24,594,784	16,608,800	204,068
Shares (Diluted)	32,722,438	29,126,314	25,851,813	24,594,784	16,608,800	204,068
EBITDA	$-16M	$-22M	$-27M	$-41M	$-24M	·

Bilanço 26

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$22M	$13M	$18M	$7M	$19M	$26M
Short-term Investments	$39M	$39M	$48M	$71M	$96M	$12M
Receivables	$13M	$13M	$12M	$7M	$7M	$8M
Inventory	$15M	$13M	$11M	$10M	$8M	$7M
Prepaid Expense	$1M	$2M	$3M	$3M	$2M	$1M
Current Assets	$94M	$81M	$93M	$98M	$133M	$55M
PP&E (Net)	$1M	$1M	$1M	$1M	$603.0K	$515.0K
PP&E (Gross)	$9M	$9M	$9M	$10M	$9M	$9M
Accum. Depreciation	$8M	$8M	$8M	$9M	$8M	$8M
Other Non-current Assets	$113.0K	$15.0K	$15.0K	$21.0K	$21.0K	$23.0K
Total Assets	$106M	$95M	$108M	$114M	$134M	$56M
Accounts Payable	$2M	$3M	$2M	$2M	$1M	$949.0K
Accrued Liabilities	$13M	$10M	$11M	$7M	$8M	$7M
Current Liabilities	$18M	$15M	$16M	$11M	$9M	$10M
Capital Leases	$10M	$12M	$14M	$15M	$0	·
Other Non-current Liabilities	·	·	·	·	$0	$274.0K
Total Liabilities	$87M	$87M	$87M	$79M	$60M	$62M
Long-term Debt	·	·	·	·	$50M	$53M
Total Debt	$59M	$60M	$57M	$53M	$50M	·
Common Stock	$34.0K	$30.0K	$28.0K	$25.0K	$24.0K	$0
Paid-in Capital	$571M	$539M	$524M	$507M	$498M	$240M
Retained Earnings	$-552M	$-531M	$-504M	$-471M	$-424M	$-388M
AOCI	·	·	$0	$-1M	$-272.0K	$33.0K
Stockholders' Equity	$19M	$8M	$21M	$35M	$74M	$-148M
Liabilities + Equity	$106M	$95M	$108M	$114M	$134M	$56M
Shares Outstanding	33,574,759	30,145,039	27,823,465	25,045,751	24,452,999	314,096

Nakit Akışı 9

Metrik	2025	2024	2023	2022	2021	2020
Stock-based Comp	$11M	$10M	$10M	$8M	$4M	$1M
Operating Cash Flow	$-11M	$-18M	$-20M	$-37M	$-25M	$-22M
CapEx	$332.0K	$306.0K	$173.0K	$603.0K	$384.0K	$62.0K
Investing Cash Flow	$-332.0K	$9M	$23M	$24M	$-85M	$-11M
Stock Repurchased	$50M	$0	·	·	·	·
Net Stock Activity	$-50M	·	·	·	·	·
Financing Cash Flow	$20M	$4M	$8M	$490.0K	$103M	$55M
Net Change in Cash	$8M	$-5M	$11M	$-13M	$-7M	$23M
Free Cash Flow	$-11M	$-18M	$-20M	$-37M	$-25M	·

Kârlılık 6

Metrik	2025	2024	2023	2022	2021	2020
Gross Margin	77.2%	73.9%	73.6%	71.4%	74.0%	·
Operating Margin	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%	·
Net Margin	-21.5%	-34.0%	-50.4%	-103.4%	-79.8%	·
EBITDA Margin	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%	·
ROA	-21.4%	-26.8%	-29.7%	-38.0%	-38.1%	·
ROE	-111.6%	-304.3%	-178.1%	-120.4%	-46.5%	·

Likidite ve Solventlik 5

Metrik	2025	2024	2023	2022	2021	2020
Current Ratio	5.3	5.4	5.7	8.9	14.3	·
Quick Ratio	4.3	4.3	4.9	7.7	13.2	·
Debt / Equity	3.1	7.4	2.8	1.5	0.7	·
LT Debt / Equity	3.1	7.4	2.8	1.5	0.7	·
Interest Coverage	·	·	-3.2	-5.4	-3.2	·

Verimlilik 3

Metrik	2025	2024	2023	2022	2021	2020
Asset Turnover	1.0	0.8	0.6	0.4	0.5	·
Inventory Turnover	1.5	1.7	1.7	1.5	1.6	·
Receivables Turnover	7.3	6.4	6.6	6.2	5.8	·

Hisse Başına 6

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$0.57	$0.27	$0.74	$1.39	$3.01	·
Revenue / Share	$3.06	$2.74	$2.53	$1.85	$2.72	·
Cash Flow / Share	$-0.34	$-0.62	$-0.76	$-1.50	$-1.48	·
Cash / Share	$0.65	$0.45	$0.65	$0.26	$0.78	·
Dividend / Share	$0.00	$0.00	$0.00	·	·	·
EPS (TTM)	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020
Revenue YoY	25.1%	22.1%	43.7%	0.75%	9.8%	·
Revenue CAGR 3Y	30.0%	20.9%	16.7%	·	·	·
Revenue CAGR 5Y	19.4%	·	·	·	·	·

Değerleme (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$100M	$80M	$65M	$46M	$45M	·
Net Income TTM	$-21M	$-27M	$-33M	$-47M	$-36M	·
Market Cap	$518M	$337M	$287M	$37M	$246M	·
Enterprise Value	$516M	$344M	$277M	$13M	$181M	·
P/E	-23.4	-12.0	-8.1	-0.8	-4.6	·
P/S	5.2	4.2	4.4	0.8	5.5	·
P/B	27.2	42.1	13.9	1.1	3.4	·
P / Tangible Book	27.2	42.1	13.9	1.1	3.4	·
P / Cash Flow	-47.1	-18.8	-14.6	-1.0	-10.0	·
P / FCF	-45.7	-18.5	-14.4	-1.0	-9.9	·
EV / EBITDA	-31.6	-15.9	-10.2	-0.3	-7.6	·
EV / FCF	-45.5	-18.8	-14.0	-0.3	-7.2	·
EV / Revenue	5.2	4.3	4.2	0.3	4.0	·
Earnings Yield	-4.3%	-8.3%	-12.3%	-128.2%	-21.5%	·

Gelir Tablosu 17

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$23M	$22M	$27M	$27M	$20M	$23M	$21M	$21M	$19M	$18M	$18M	$16M	$17M	$14M	$13M	$11M
Cost of Revenue	$4M	$4M	$6M	$6M	$3M	$5M	$5M	$6M	$5M	$5M	$4M	$4M	$5M	$4M	$4M	$3M
Gross Profit	$19M	$18M	$21M	$21M	$16M	$17M	$16M	$15M	$14M	$13M	$14M	$12M	$12M	$10M	$9M	$8M
R&D Expense	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M	$6M	$6M	$5M	$5M	$5M	$5M	$5M	$6M
SG&A Expense	$5M	$5M	$-7M	$5M	$6M	$4M	$-6M	$4M	$5M	$15M	$13M	$13M	$14M	$13M	$14M	$13M
Operating Expenses	$24M	$24M	$22M	$24M	$24M	$22M	$20M	$20M	$20M	$21M	$19M	$18M	$20M	$19M	$19M	$18M
Operating Income	$-5M	$-6M	$-2M	$-3M	$-8M	$-5M	$-4M	$-4M	$-6M	$-8M	$-5M	$-6M	$-8M	$-8M	$-10M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	$2M	·	$2M	$2M	$2M	$2M	$2M
Interest Income	$523.0K	$565.0K	$638.0K	$667.0K	$718.0K	$793.0K	$681.0K	$754.0K	$762.0K	$827.0K	$822.0K	$769.0K	$733.0K	$726.0K	$800.0K	$423.0K
Other Non-op	$-41.0K	$-165.0K	$0	$82.0K	$-486.0K	$-82.0K	$-86.0K	$219.0K	$120.0K	$51.0K	$265.0K	$115.0K	$122.0K	$-817.0K	$-146.0K	$-103.0K
Income Tax	·	$0	$0	$0	$0	$0	·	$0	$0	$0	·	$0	$0	$0	·	$0
Net Income	$-6M	$-7M	$-3M	$-3M	$-9M	$-7M	$-5M	$-5M	$-8M	$-9M	$-6M	$-7M	$-9M	$-10M	$-11M	$-12M
EPS (Basic)	$-0.18	$-0.20	$-0.08	$-0.11	$-0.26	$-0.21	$-0.16	$-0.19	$-0.26	$-0.32	$-0.22	$-0.28	$-0.36	$-0.41	$-0.44	$-0.48
EPS (Diluted)	$-0.18	$-0.20	$-0.08	$-0.11	$-0.26	$-0.21	$-0.16	$-0.19	$-0.26	$-0.32	$-0.22	$-0.28	$-0.36	$-0.41	$-0.44	$-0.48
Shares (Basic)	34,104,430	33,716,813	·	33,134,606	32,863,031	31,480,911	·	29,444,625	28,853,216	28,285,176	·	26,017,329	25,472,526	25,097,262	·	24,728,701
Shares (Diluted)	34,104,430	33,716,813	·	33,134,606	32,863,031	31,480,911	·	29,444,625	28,853,216	28,285,176	·	26,017,329	25,472,526	25,097,262	·	24,728,701
EBITDA	$-5M	$-6M	·	$-3M	$-7M	$-5M	·	$-4M	$-6M	$-8M	·	$-6M	$-8M	$-8M	·	$-10M

Bilanço 24

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$13M	$15M	$22M	$21M	$23M	$27M	$13M	$15M	$13M	$13M	$18M	$10M	$8M	$7M	$7M	$6M
Short-term Investments	$39M	$39M	$39M	$39M	$39M	$39M	$39M	$41M	$43M	$46M	$48M	$52M	$56M	$61M	$71M	·
Receivables	$15M	$15M	$15M	$15M	$14M	$15M	$13M	$12M	$11M	$12M	$12M	$11M	$11M	$9M	$7M	$8M
Inventory	$18M	$17M	$17M	$18M	$16M	$14M	$13M	$12M	$11M	$11M	$11M	$10M	$10M	$11M	$10M	$9M
Prepaid Expense	$1M	$2M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$3M	$3M	$3M
Current Assets	$86M	$87M	$94M	$95M	$94M	$97M	$81M	$83M	$80M	$84M	$93M	$84M	$87M	$90M	$98M	$104M
PP&E (Net)	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$998.0K	$1M	$1M	$949.0K	$976.0K	$1M	$1M	$894.0K
PP&E (Gross)	$10M	$10M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$10M	$10M	$10M	$10M	$10M
Accum. Depreciation	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$9M	$9M	$9M	$9M	$9M
Other Non-current Assets	$98.0K	$106.0K	$113.0K	$120.0K	$87.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$15.0K	$21.0K	$21.0K	$21.0K	$21.0K
Total Assets	$97M	$99M	$106M	$107M	$106M	$110M	$95M	$96M	$94M	$99M	$108M	$99M	$102M	$106M	$114M	$120M
Accounts Payable	$4M	$5M	$2M	$5M	$5M	$4M	$3M	$2M	$2M	$3M	$2M	$1M	$2M	$2M	$2M	$1M
Accrued Liabilities	$11M	$9M	$13M	$12M	$10M	$8M	$10M	$10M	$8M	$7M	$11M	$10M	$8M	$7M	$7M	$8M
Current Liabilities	$17M	$16M	$18M	$20M	$17M	$15M	$15M	$15M	$13M	$13M	$16M	$13M	$12M	$10M	$11M	$9M
Capital Leases	$9M	$9M	$10M	$10M	$11M	$11M	$12M	$12M	$13M	$13M	$14M	$14M	$15M	$15M	$15M	$16M
Total Liabilities	$85M	$84M	$87M	$89M	$87M	$86M	$87M	$86M	$85M	$85M	$87M	$83M	$81M	$79M	$79M	$77M
Total Debt	$59M	$59M	·	$59M	$59M	$60M	·	$59M	$59M	$58M	·	$56M	$55M	$54M	·	$52M
Common Stock	$34.0K	$34.0K	$34.0K	$33.0K	$33.0K	$33.0K	$30.0K	$30.0K	$29.0K	$29.0K	$28.0K	$26.0K	$26.0K	$25.0K	$25.0K	$25.0K
Paid-in Capital	$577M	$574M	$571M	$568M	$566M	$562M	$539M	$535M	$530M	$527M	$524M	$514M	$512M	$509M	$507M	$504M
Retained Earnings	$-565M	$-559M	$-552M	$-550M	$-546M	$-538M	$-531M	$-526M	$-520M	$-513M	$-504M	$-498M	$-490M	$-481M	$-471M	$-460M
AOCI	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$-1M	$-1M
Stockholders' Equity	$12M	$14M	$19M	$19M	$19M	$24M	$8M	$10M	$10M	$14M	$21M	$16M	$21M	$27M	$35M	$43M
Liabilities + Equity	$97M	$99M	$106M	$107M	$106M	$110M	$95M	$96M	$94M	$99M	$108M	$99M	$102M	$106M	$114M	$120M
Shares Outstanding	34,282,567	33,909,408	33,574,759	33,280,887	33,044,371	32,751,240	30,145,039	29,777,966	29,139,206	28,717,452	27,823,465	26,244,935	25,816,929	25,352,204	25,045,751	24,864,119

Nakit Akışı 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$3M	$2M	$2M	$2M
Operating Cash Flow	$-4M	$-6M	$506.0K	$-2M	$-2M	$-7M	$-5M	$-2M	$-4M	$-8M	$-3M	$-2M	$-4M	$-10M	$-8M	$-7M
CapEx	$125.0K	$117.0K	$97.0K	$30.0K	$168.0K	$37.0K	$39.0K	$100.0K	$63.0K	$104.0K	$32.0K	$9.0K	$0	$132.0K	$102.0K	$31.0K
Investing Cash Flow	$-125.0K	$-117.0K	$-97.0K	$-30.0K	$-168.0K	$-37.0K	$2M	$1M	$3M	$2M	$3M	$4M	$5M	$10M	$9M	$7M
Stock Repurchased	$0	$0	$0	$0	$0	$50M	$0	$0	$0	$0	·	·	·	·	·	·
Net Stock Activity	·	$0	·	·	·	$-50M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$1M	$-166.0K	$635.0K	$-235.0K	$-2M	$21M	$848.0K	$3M	$509.0K	$72.0K	$8M	$-27.0K	$195.0K	$-255.0K	$-138.0K	$-8.0K
Net Change in Cash	$-3M	$-6M	$1M	$-2M	$-4M	$14M	$-2M	$3M	$-154.0K	$-5M	$8M	$2M	$1M	$115.0K	$917.0K	$-14.0K
Free Cash Flow	·	$-6M	·	·	·	$-8M	·	·	·	$-8M	·	·	·	$-10M	·	·

Kârlılık 6

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	82.8%	81.8%	·	77.4%	77.1%	77.0%	·	73.2%	73.4%	73.6%	·	74.5%	72.5%	71.7%	·	71.4%
Operating Margin	-22.5%	-25.2%	·	-9.5%	-29.0%	-22.9%	·	-20.2%	-32.4%	-41.6%	·	-36.2%	-47.6%	-57.5%	·	-91.4%
Net Margin	-27.2%	-30.3%	·	-12.8%	-36.8%	-29.2%	·	-25.9%	-39.0%	-49.2%	·	-44.2%	-55.3%	-71.7%	·	-105.6%
EBITDA Margin	-22.5%	-25.2%	·	-9.5%	-29.0%	-22.9%	·	-20.2%	-32.4%	-41.6%	·	-36.2%	-47.6%	-57.5%	·	-91.4%
ROA	-6.1%	-6.4%	·	-3.4%	-8.6%	-6.3%	·	-5.6%	-7.6%	-8.7%	·	-6.6%	-8.3%	-8.8%	·	-9.0%
ROE	-39.6%	-34.5%	·	-24.7%	-59.0%	-34.1%	·	-41.6%	-48.3%	-42.7%	·	-24.3%	-24.6%	-23.0%	·	-18.8%

Likidite ve Solventlik 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.9	5.4	·	4.9	5.5	6.6	·	5.6	6.4	6.4	·	6.6	7.5	9.1	·	11.1
Quick Ratio	3.8	4.3	·	3.8	4.4	5.6	·	4.6	5.3	5.4	·	5.7	6.5	7.8	·	1.4
Debt / Equity	5.0	4.1	·	3.2	3.0	2.5	·	6.0	6.0	4.0	·	3.4	2.6	2.0	·	1.2
LT Debt / Equity	5.0	4.1	·	3.2	3.0	2.5	·	6.0	6.0	4.0	·	3.4	2.6	2.0	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	-3.3	·	-2.7	-3.7	-4.2	·	-5.4

Verimlilik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.2	0.2	·	0.3	0.2	0.2	·	0.2	0.2	0.2	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.2	0.3	·	0.4	0.4	0.4	·	0.5	0.5	0.4	·	0.5	0.5	0.4	·	0.4
Receivables Turnover	1.6	1.5	·	2.1	1.9	1.7	·	1.8	1.7	1.7	·	1.7	1.7	1.6	·	1.5

Hisse Başına 6

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.35	$0.43	·	$0.56	$0.59	$0.74	·	$0.33	$0.34	$0.50	·	$0.62	$0.82	$1.08	·	$1.75
Revenue / Share	$0.67	$0.65	·	$0.83	$0.72	$0.72	·	$0.72	$0.67	$0.64	·	$0.63	$0.65	$0.58	·	$0.45
Cash Flow / Share	·	$-0.17	·	·	·	$-0.24	·	·	·	$-0.27	·	·	·	$-0.39	·	·
Cash / Share	$0.37	$0.44	·	$0.62	$0.69	$0.82	·	$0.52	$0.44	$0.45	·	$0.37	$0.30	$0.27	·	$0.23
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	·	·	·	·	·	·	·	·	·	·
EPS (TTM)	$-0.57	$-0.65	·	$-0.74	$-0.82	$-0.82	·	$-0.99	$-1.08	$-1.18	·	$-1.49	$-1.69	$-1.85	·	$29.91

Değerleme (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$99M	$96M	·	$91M	$85M	$84M	·	$76M	$72M	$69M	·	$60M	$55M	$49M	·	$44M
Net Income TTM	$-19M	$-22M	·	$-24M	$-26M	$-25M	·	$-28M	$-30M	$-32M	·	$-38M	$-42M	$-46M	·	$-47M
Market Cap	$545M	$446M	·	$343M	$368M	$403M	·	$208M	$220M	$379M	·	$255M	$116M	$118M	·	$93M
Enterprise Value	$552M	$451M	·	$342M	$365M	$396M	·	$210M	$224M	$378M	·	$250M	$107M	$104M	·	$140M
P/E	-27.9	-20.2	·	-13.9	-13.6	-15.0	·	-7.0	-7.0	-11.2	·	-6.5	-2.7	-2.5	·	0.1
P/S	5.5	4.7	·	3.8	4.4	4.8	·	2.7	3.1	5.5	·	4.2	2.1	2.4	·	2.1
P/B	45.8	30.9	·	18.5	18.9	16.6	·	21.1	22.3	26.4	·	15.6	5.5	4.3	·	2.1
P / Tangible Book	45.8	30.9	·	18.5	18.9	16.6	·	21.1	22.3	26.4	·	15.6	5.5	4.3	·	2.1
P / Cash Flow	·	-75.6	·	·	·	-53.8	·	·	·	-50.4	·	·	·	-12.1	·	·
EV / Revenue	5.6	4.7	·	3.8	4.3	4.7	·	2.7	3.1	5.5	·	4.2	2.0	2.1	·	3.2
Earnings Yield	-3.6%	-4.9%	·	-7.2%	-7.4%	-6.7%	·	-14.2%	-14.3%	-8.9%	·	-15.3%	-37.6%	-39.9%	·	797.6%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$100M	$80M	$65M	$46M	$45M
Brüt Kâr Marjı %	77.2%	73.9%	73.6%	71.4%	74.0%
Faaliyet Kâr Marjı %	-16.3%	-27.1%	-41.5%	-89.6%	-52.5%
Net Gelir	$-21M	$-27M	$-33M	$-47M	$-36M
Seyreltilmiş Hisse Başı Kâr	$-0.66	$-0.93	$-1.27	$-1.91	$-2.17

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	3.1	7.4	2.8	1.5	0.7
Cari Oran	5.3	5.4	5.7	8.9	14.3
Cari Oran	4.3	4.3	4.9	7.7	13.2

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-11M	$-18M	$-20M	$-37M	$-25M

Kurumsal Sahipler (13F) 117 dosya · $464.2M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 117

Tutulan Değer $464.2M

Yeni pozisyonlar 19

Çıkan pozisyonlar 18

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
19 (-10 önceki Ç'ye göre)	18 (+8 önceki Ç'ye göre)	47 (+9 önceki Ç'ye göre)	35 (0 önceki Ç'ye göre)	+120K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
Polar Capital Holdings Plc	$52.406.873	3.298.104	11,29%	Hisse senetleri
Soleus Capital Management, L.P.	$46.257.729	2.911.122	9,96%	Hisse senetleri
First Light Asset Management, LLC	$45.463.944	2.861.167	9,79%	Hisse senetleri
MORGAN STANLEY	$42.178.273	2.654.391	9,09%	Hisse senetleri
BlackRock, Inc.	$39.369.112	2.477.603	8,48%	Hisse senetleri
ORBIMED ADVISORS LLC	$23.916.436	1.505.125	5,15%	Hisse senetleri
Driehaus Capital Management LLC	$22.999.043	1.447.391	4,95%	Hisse senetleri
VANGUARD GROUP INC	$22.885.600	1.482.228	4,93%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$19.498.174	1.227.072	4,20%	Hisse senetleri
DEUTSCHE BANK AG\	$14.919.423	938.919	3,21%	Hisse senetleri
ARMISTICE CAPITAL, LLC	$10.995.880	692.000	2,37%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$10.589.998	666.300	2,28%	Hisse senetleri
Kent Lake PR LLC	$10.310.000	1.000.000	2,22%	Hisse senetleri
KOTLER KEVIN	$9.749.866	631.468	2,10%	Hisse senetleri
FMR LLC	$8.815.311	554.771	1,90%	Hisse senetleri
STATE STREET CORP	$8.741.597	550.132	1,88%	Hisse senetleri
SILVERCREST ASSET MANAGEMENT GROUP LLC	$5.468.130	344.124	1,18%	Hisse senetleri
NORTHERN TRUST CORP	$4.131.798	260.025	0,89%	Hisse senetleri
Qube Research & Technologies Ltd	$3.515.456	221.237	0,76%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.501.695	220.371	0,75%	Hisse senetleri
Palumbo Wealth Management LLC	$3.324.173	209.199	0,72%	Hisse senetleri
ESSEX INVESTMENT MANAGEMENT CO LLC	$3.316.291	208.703	0,71%	Hisse senetleri
ALGERT GLOBAL LLC	$2.936.059	184.774	0,63%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$2.900.465	182.534	0,62%	Hisse senetleri
JPMORGAN CHASE & CO	$2.864.831	173.311	0,62%	Hisse senetleri
HighMark Wealth Management LLC	$2.590.070	163.000	0,56%	Hisse senetleri
Russell Investments Group, Ltd.	$2.576.783	162.164	0,56%	Hisse senetleri
D. E. Shaw & Co., Inc.	$2.559.577	161.081	0,55%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$2.376.604	149.566	0,51%	Hisse senetleri
CITADEL ADVISORS LLC	$2.046.632	128.800	0,44%	Hisse senetleri
LAZARD ASSET MANAGEMENT LLC	$2.029.598	127.728	0,44%	Hisse senetleri
PANAGORA ASSET MANAGEMENT INC	$1.812.398	114.059	0,39%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$1.774.897	111.699	0,38%	Hisse senetleri
TUDOR INVESTMENT CORP ET AL	$1.745.898	109.874	0,38%	Hisse senetleri
Nuveen, LLC	$1.581.023	99.498	0,34%	Hisse senetleri
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	$1.506.372	94.800	0,32%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$1.393.188	87.677	0,30%	Hisse senetleri
Man Group plc	$1.335.920	84.073	0,29%	Hisse senetleri
NORGES BANK	$1.269.611	79.900	0,27%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.236.735	77.831	0,27%	Hisse senetleri
Legato Capital Management LLC	$1.117.607	70.334	0,24%	Hisse senetleri
SEI INVESTMENTS CO	$987.993	62.177	0,21%	Hisse senetleri
Bank of New York Mellon Corp	$921.255	57.977	0,20%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$788.984	51.100	0,17%	Hisse senetleri
Informed Momentum Co LLC	$630.134	39.656	0,14%	Hisse senetleri
AQR CAPITAL MANAGEMENT LLC	$570.769	35.920	0,12%	Hisse senetleri
JANE STREET GROUP, LLC	$547.220	34.438	0,12%	Hisse senetleri
RHUMBLINE ADVISERS	$503.131	31.664	0,11%	Hisse senetleri
BARCLAYS PLC	$492.765	31.011	0,11%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$486.536	30.619	0,10%	Hisse senetleri

Tüm 117 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 1 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Accelmed Partners II LP, Accelmed Partners II GP, L.P., Accelmed Partners II, LLC, Uri Geiger ×2 başvurular	23 Kasım 2022	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 17 içeriden öğrenenler · 6 yöneticiler · 11 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Joel Becker	CHIEF EXECUTIVE OFFICER	03 Eylül 2026 F	138.000	0	$0
Michael Favet	Chief Executive Officer	21 Şubat 2023 A	407.080	0	$0
Patrick F. Williams	Chief Financial Officer	20 Eylül 2026 F	67.508	0	$0
Rebecca Kuhn	CHIEF FINANCIAL OFFICER	03 Haziran 2025 F	131.613	0	$0
Martha Morrell	CHIEF MEDICAL OFFICER	24 Eylül 2026 F	51.357	1	$-399.250
Irina Ridley	Chief Legal Officer/Secretary	20 Şubat 2023 A	141.139	0	$0
Rakhi Kumar	Yönetim kurulu üyesi	19 Haziran 2026 A	23.039	0	$0
Uri Geiger	Yönetim kurulu üyesi	19 Haziran 2026 A	18.537	0	$0
Frank M Fischer	Yönetim kurulu üyesi	19 Haziran 2026 A	599.534	0	$0
Renee Ryan	Yönetim kurulu üyesi	05 Haziran 2026 A	2.890	0	$0
Lisa Andrade	Yönetim kurulu üyesi	05 Haziran 2026 A	2.890	0	$0
Scott R Huennekens	Yönetim kurulu üyesi	05 Haziran 2026 A	2.890	0	$0
Joseph Lacob	Yönetim kurulu üyesi	20 Mart 2026 A	14.754	0	$0
Greg Shaw Garfield	Yönetim kurulu üyesi	13 Haziran 2022 A	5.614.384	0	$0
Evan Norton	Yönetim kurulu üyesi	21 Nisan 2021 A	4.042.657	0	$0
KCK LTD.	10% sahip	20 Şubat 2025 S	0	0	$0
Accelmed Partners II L.P.	10% sahip	22 Kasım 2022 P	4.432.948	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 11 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IBRN · iShares Trust	0,38%	2.057 SH	11 Eylül 2026	Günlük
IWC · iShares Trust	0,09%	89.476 SH	11 Eylül 2026	Günlük
IWO · iShares Trust	0,02%	248.901 SH	11 Eylül 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,02%	28.462 SH	19 Ağustos 2026	Günlük
IWM · iShares Trust	0,01%	676.027 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,01%	12.674 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	152.437 SH	19 Ağustos 2026	Günlük
IWV · iShares Trust	0,00%	11.385 SH	03 Eylül 2026	Günlük
VXF · VANGUARD INDEX FUNDS	0,00%	290.278 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	908.479 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	1.828 SH	19 Ağustos 2026	Günlük

NPCE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 15 analist AL

Medyan hedef $20.00 +57,5%

4 26,7% Güçlü Al

10 66,7% Al

1 6,7% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

10 analist · 2026-10-04

Ortalama hedef $20.00 +57,5%

← Tüm hedeflerin altında Mevcut fiyat $12.70

Düşük$18.00 Ortalama$20.00 Yüksek$22.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
NPCE	$518M	-23.4	25.1%	-21.5%	-111.6%	77.2%
DCTH	$350M	144.3	129.1%	3.2%	2.5%	86.2%
SENS	$228M	-3.3	56.9%	-196.0%	-88.7%	44.7%
TCMD	$651M	35.4	12.5%	5.8%	9.2%	75.9%
SGHT	$424M	-10.7	-3.1%	-49.7%	-57.4%	86.2%
SI	$295M	-3.1	49.6%	-85.3%	-129.1%	76.5%
CARL	$329M	-5.8	85.9%	-58.7%	-375.2%	75.3%
OFIX	$604M	-6.5	2.9%	-11.2%	-20.3%	68.8%
OBIO	$237M	-3.7	1169.2%	-157.4%	-195.7%	·
CLPT	$402M	-15.2	17.8%	-69.1%	-106.9%	61.4%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

NPCE Neuropace, Inc. - Common Stock